research-peptide and compounded forms are not FDA-approved and are sold for research purposes only
They are smaller, more targeted, and in many cases can be administered through multiple routes including topical application, subcutaneous injection, or oral delivery
reported improvements in clinical attachment level (CAL), probing depth (PD), gingival recession (REC) , and probing bone levels, after using hyaluronic acid hydrogel scaffolds enriched with fibroblast growth factor type 2 (fhFGF-2) in the surgical treatment of periodontal intrabony defects
Mid-portion tendinopathy typically responds faster than insertional problems due to easier injection access and slightly better baseline vascularity
PMID: 27847966
Bacteriostatic water for injection is not routinely available as a licensed product in the UK in the same way it is in the United States